APA (7th ed.) Citation

JD, G., F, H., & SA, P. (2023). Can Mechanistic Static Models for Drug-Drug Interactions Support Regulatory Filing for Study Waivers and Label Recommendations? Clinical pharmacokinetics, 62(3), 457. https://doi.org/10.1007/s40262-022-01204-4

Chicago Style (17th ed.) Citation

JD, Gomez-Mantilla, Huang F, and Peters SA. "Can Mechanistic Static Models for Drug-Drug Interactions Support Regulatory Filing for Study Waivers and Label Recommendations?" Clinical Pharmacokinetics 62, no. 3 (2023): 457. https://doi.org/10.1007/s40262-022-01204-4.

MLA (9th ed.) Citation

JD, Gomez-Mantilla, et al. "Can Mechanistic Static Models for Drug-Drug Interactions Support Regulatory Filing for Study Waivers and Label Recommendations?" Clinical Pharmacokinetics, vol. 62, no. 3, 2023, p. 457, https://doi.org/10.1007/s40262-022-01204-4.